← Back to Investors

Lundbeckfonden BioCapital

Lundbeckfonden BioCapital is the venture capital arm of the Lundbeck Foundation, one of Denmark's largest commercial foundations. They specialize in life sciences investments with particular expertise in neuroscience, reflecting the foundation's heritage from Lundbeck pharmaceuticals.

Location
Copenhagen, Denmark
Founded
2009
AUM
€700M+
Investment Range
€5M - €50M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth

Investment Thesis

Lundbeckfonden BioCapital invests in innovative life sciences companies with a particular focus on neuroscience, reflecting their deep expertise in the field. They support companies from early stage through growth, bringing patient capital and scientific expertise from the Lundbeck Foundation ecosystem.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Peter Harkjaer - Managing Director
  • Christian Elling, PhD - Investment Director

Other Key Team Members

  • Scientific advisors from Lundbeck and academic network

Focus Areas

  • Neuroscience (CNS disorders, neurodegeneration)
  • Biotechnology
  • Therapeutics
  • Drug discovery
  • Nordic life sciences
  • European biotech

Notable Exits

  • Asceneuron - $100M Series C (2024, Alzheimer's disease)
  • Strong track record in neuroscience investments
  • Multiple exits through M&A and partnerships

Sources